Vivoryon Therapeutics AG to Publish its Half Year 2020 Results on August 27, 2020

On August 20, 2020 Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835), reported that it will publish its Half Year Results for 2020 on Thursday, August 27, 2020 (Press release, Vivoryon Therapeutics, AUG 20, 2020, View Source [SID1234563900]). The company will host a conference call and webcast (in English) open to the public. The Half Year Results 2020 will be available to download on the company website (www.vivoryon.com/investors-news/financial-information/).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

Conference call details

Date: Thursday, August 27, 2020

Time: 3:00 pm CEST /09:00 am EDT

Webcast details

A live webcast and accompanying slides will be made available at: www.vivoryon.com/investors-news/financial-information/

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!